State Street’s AIM ImmunoTech AIM Stock Holding History
Bought
Maintained
Sold
Other funds holding AIM
CB
HI
HI
DB
State Street's AIM Position: Q2 2025 in Review
State Street sold out of AIM ImmunoTech (AIM) in Q2 2025, closing a stake of 1,733 shares — an estimated $21.2K sold.
State Street first reported a position in AIM in Q2 2013 and held it in 29 quarters. The position peaked at $345K in Q2 2021. 12 funds tracked by Wall St. Rank hold AIM as of Q2 2025.
- State Street reported no remaining AIM ImmunoTech position as of Q2 2025 after selling out during the quarter.
- State Street sold 1,733 AIM ImmunoTech shares in Q2 2025, an estimated $21.2K.
- State Street first reported a position in AIM ImmunoTech in Q2 2013 and held it in 29 quarters.
- State Street's AIM ImmunoTech position peaked at $345K in Q2 2021.
- 12 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q2 2025.
Based on State Street's 13F filing for Q2 2025, filed 14 Aug 2025.